Department of Physiology, Midwestern University, Downers Grove, IL; Department of Surgery, Vanderbilt University Medical Center, Nashville, TN.
Department of Surgery, Vanderbilt University Medical Center, Nashville, TN.
Am J Clin Nutr. 2023 Sep;118(3):646-656. doi: 10.1016/j.ajcnut.2023.06.011. Epub 2023 Aug 8.
Intestinal nutrient sensing regulates food intake and energy metabolism by acting locally and relaying nutritional status to the brain. It is unclear whether these mechanisms are altered in obese humans.
We aimed to investigate differences in duodenal nutrient sensing in humans with or without obesity and the effects of transiently blocking vagal transmission on nutrient sensing, hunger, and appetite.
In a single-blinded, randomized, cross-over design, subjects with or without obesity (n = 14 and n = 11, respectively) were infused intraduodenally with saline or a combination of glucose and oleic acid for 90 min (glucose load: 22.5 g, 1 kcal/min; oleic acid load: 10 g, 1 kcal/min) in the presence or absence of local anesthetic (benzocaine). Blood was sampled at 10-min intervals (120-240 min) and 15-min intervals until termination of the study for measurements of gut hormones, insulin, leptin, and C-peptide. Hunger and satiety sensations were scored using the visual analog scale, and hepatic glucose production and glucose oxidation rates were measured.
Duodenal nutrient infusion in lean subjects led to a 65% drop in acyl ghrelin release and robustly increased cholecystokinin 8 (CCK-8) release (65%; P = 0.023); benzocaine infusion delayed this response (2-factor repeated-measures analysis of variance, P = 0.0065). In contrast, subjects with obesity had significantly blunted response to nutrient infusion, and no further effects were observed with benzocaine. Additionally, significant delays were observed in peptide YY (3-36), pancreatic polypeptide, glucose inhibitory peptide, and glucagon-like peptide 1 (7-36) response. No significant interactions were found between body mass index (BMI) or baseline hormone levels and areas under the curve for hormones except CCK-8 (BMI, P = 0.018; baseline CCK, P = 0.013). Nutrient-induced hunger and satiety sensations were impeded by benzocaine only in the lean cohort. Hunger and satiety sensations in subjects with obesity were not responsive to nutrient entry into the duodenum, and no additional effects were observed by blocking neural signaling.
Nutrient-induced gut hormone release and response to transient vagal blockade are significantly blunted in subjects with obesity. This trial was registered at clinicaltrials.org as NCT02537314.
肠道营养感应通过局部作用和将营养状况传递给大脑来调节食物摄入和能量代谢。目前尚不清楚这些机制在肥胖人群中是否发生了改变。
我们旨在研究肥胖人群和非肥胖人群的十二指肠营养感应是否存在差异,以及短暂阻断迷走神经传递对营养感应、饥饿感和食欲的影响。
采用单盲、随机、交叉设计,分别纳入肥胖患者(n=14)和非肥胖患者(n=11),在存在或不存在局部麻醉(苯佐卡因)的情况下,十二指肠内输注生理盐水或葡萄糖和油酸混合物 90 分钟(葡萄糖负荷:22.5g,1kcal/min;油酸负荷:10g,1kcal/min)。在 120-240 分钟和研究结束前的 15 分钟间隔内,每隔 10 分钟采集一次血液,以测量肠道激素、胰岛素、瘦素和 C 肽。使用视觉模拟量表评分饥饿感和饱腹感,测量肝葡萄糖生成和葡萄糖氧化率。
在瘦受试者中,十二指肠营养输注导致酰基 ghrelin 释放减少 65%,并显著增加胆囊收缩素 8(CCK-8)释放(65%;P=0.023);苯佐卡因输注延迟了这种反应(2 因素重复测量方差分析,P=0.0065)。相比之下,肥胖患者对营养输注的反应明显减弱,并且苯佐卡因没有进一步的影响。此外,还观察到肽 YY(3-36)、胰多肽、葡萄糖抑制肽和胰高血糖素样肽 1(7-36)的反应显著延迟。除 CCK-8 外(BMI,P=0.018;基础 CCK,P=0.013),在激素的曲线下面积方面,体重指数(BMI)或基线激素水平与激素之间没有发现显著的相互作用。只有在瘦受试者中,苯佐卡因才会干扰营养引起的饥饿感和饱腹感。肥胖患者的饥饿感和饱腹感对十二指肠内营养物质的摄入没有反应,并且阻断神经信号也没有观察到额外的影响。
肥胖患者的营养感应引起的肠道激素释放和对短暂迷走神经阻断的反应明显减弱。本试验在 clinicaltrials.org 上注册为 NCT02537314。